First Bank & Trust Gilead Sciences, Inc. Transaction History

First Bank & Trust

$510 Million
Q3 2024

A detailed history of First Bank & Trust transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Bank & Trust holds 51,575 shares of GILD stock, worth $4.65 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

51,575

Previous 50,005 3.14%

Holding current value

$4.65 Million

Previous $3.43 Million 26.03%

% of portfolio

0.85%

Previous 0.72%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$66.59 - $83.99 $104,546 - $131,864	1,570 Added 3.14%	51,575 $4.32 Million
Q2 2024 Jul 09, 2024	BUY	$63.15 - $72.88 $741,128 - $855,319	11,736 Added 30.67%	50,005 $3.43 Million
Q1 2024 Apr 17, 2024	BUY	$71.58 - $87.29 $183,889 - $224,248	2,569 Added 7.2%	38,269 $2.8 Million
Q4 2023 Jan 12, 2024	SELL	$73.27 - $83.09 $88,656 - $100,538	-1,210 Reduced 3.28%	35,700 $2.89 Million
Q3 2023 Oct 11, 2023	SELL	$73.94 - $80.67 $57,007 - $62,196	-771 Reduced 2.05%	36,910 $2.77 Million
Q2 2023 Jul 12, 2023	SELL	$76.01 - $86.7 $295,830 - $337,436	-3,892 Reduced 9.36%	37,681 $2.9 Million
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $1.65 Million - $1.88 Million	-21,341 Reduced 33.92%	41,573 $3.45 Million
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $95,848 - $137,604	1,538 Added 2.51%	62,914 $5.4 Million
Q3 2022 Oct 28, 2022	BUY	$59.54 - $68.01 $227,561 - $259,934	3,822 Added 6.64%	61,376 $3.79 Million
Q2 2022 Jul 22, 2022	BUY	$57.72 - $65.01 $455,526 - $513,058	7,892 Added 15.89%	57,554 $3.56 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $374,452 - $469,229	6,465 Added 14.97%	49,662 $2.95 Million
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $18,490 - $20,987	285 Added 0.66%	43,197 $3.14 Million
Q3 2021 Oct 18, 2021	BUY	$67.69 - $73.03 $43,321 - $46,739	640 Added 1.51%	42,912 $3 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $19,041 - $20,805	300 Added 0.71%	42,272 $2.91 Million
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $206,880 - $236,050	3,448 Added 8.95%	41,972 $2.71 Million
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $715,829 - $815,653	12,636 Added 48.81%	38,524 $2.25 Million
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $20,803 - $26,156	335 Added 1.31%	25,888 $1.64 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $850,356 - $987,420	-11,755 Reduced 31.51%	25,553 $1.97 Million
Q1 2020 Apr 14, 2020	BUY	$62.63 - $80.22 $485,883 - $622,346	7,758 Added 26.25%	37,308 $2.79 Million
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $103,891 - $114,277	1,686 Added 6.05%	29,550 $1.92 Million
Q3 2019 Oct 17, 2019	BUY	$62.51 - $69.0 $1.66 Million - $1.83 Million	26,519 Added 1971.67%	27,864 $1.77 Million
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $26,604 - $29,833	-430 Reduced 24.23%	1,345 $91,000
Q1 2019 Apr 15, 2019	SELL	$62.53 - $70.05 $20,072 - $22,486	-321 Reduced 15.31%	1,775 $115,000
Q4 2018 Jan 28, 2019	BUY	$60.54 - $79.0 $4,358 - $5,688	72 Added 3.56%	2,096 $131,000
Q3 2018 Oct 10, 2018	SELL	$71.28 - $78.92 $1,782 - $1,973	-25 Reduced 1.22%	2,024 $154,000
Q2 2018 Jul 31, 2018	BUY	$64.88 - $75.68 $5,709 - $6,659	88 Added 4.49%	2,049 $145,000
Q4 2017 Jan 18, 2018	BUY	$71.15 - $83.52 $8,466 - $9,938	119 Added 6.46%	1,961 $140,000
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $132,826 - $157,435	1,842	1,842 $149,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.

Account